Jaguar Health Inc (JAGX)
4.22
-0.07
(-1.63%)
USD |
NASDAQ |
May 31, 16:00
4.11
-0.11
(-2.61%)
Pre-Market: 09:22
Jaguar Health Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | |
December 31, 2022 | -0.361M |
September 30, 2022 | -0.056M |
June 30, 2022 | -1.258M |
March 31, 2022 | 0.00 |
December 31, 2021 | 10.48M |
September 30, 2021 | -10.48M |
June 30, 2021 | -0.006M |
March 31, 2021 | |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | -0.007M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.007M |
June 30, 2019 | -0.007M |
March 31, 2019 | 0.00 |
Date | Value |
---|---|
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | -0.0065M |
December 31, 2017 | -0.0113M |
September 30, 2017 | -1.546M |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.4773M |
September 30, 2016 | 0.1498M |
June 30, 2016 | 1.664M |
March 31, 2016 | 0.093M |
December 31, 2015 | 1.50M |
September 30, 2015 | -4.503M |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | -0.0551M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-10.48M
Minimum
Sep 2021
10.48M
Maximum
Dec 2021
-0.0993M
Average
--
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
BioSig Technologies Inc | 0.00 |
BioVie Inc | 0.00 |
Entero Therapeutics Inc | 0.0882M |
Genprex Inc | -0.0158M |
Adial Pharmaceuticals Inc | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -7.047M |
Cash from Financing (Quarterly) | 12.27M |
Free Cash Flow | -30.34M |
Free Cash Flow Per Share (Quarterly) | -2.662 |
Free Cash Flow to Equity (Quarterly) | -3.30M |
Free Cash Flow to Firm (Quarterly) | -6.436M |
Free Cash Flow Yield | -611.7% |